Individual Follow-up After Rectal Cancer - Focus on the Needs of the Patient

NCT03622437 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 336

Last updated 2022-06-14

No results posted yet for this study

Summary

With an increasing number of rectal cancer (RC) survivors, we see a rising attention to the late adverse effects following treatment of RC.

Late adverse effects that are highly prevalent and negatively impact patients' symptom burden and quality of life are: bowel-, urological and sexual dysfunctions; psychological distress; fear of recurrence. The current follow-up program primarily focuses on detection of recurrence, with less attention to late adverse effects.

In a patient-led follow-up program, the surveillance for recurrent disease is combined with detection and treatment of late adverse effects and supportive survivorship care. The follow-up involves a high degree of patient-involvement, aiming at meeting the individual patient's needs.

The patient-led follow-up programme is based on a standardized patient-education in order to enforce the patients to assess and respond sufficiently to symptoms and health problems. In case of symptoms and concerns, the patients are instructed to consult a health professional for adequate assistance and intervention.

The intervention is tested in a multicenter randomized trial, comparing the patient-led follow-up to standard routine follow-up, involving prescheduled outpatient visits.

Conditions

  • Rectal Neoplasms

Interventions

BEHAVIORAL

Patient-led follow-up

1. Patient-education, with information about signs of recurrent disease (alarm-symptoms), potential late effects, and how these can be managed. 2. The patients are instructed to contact a specialist nurse in case of alarm-symptoms, concerns or other problems related to the cancer disease throughout the entire follow-up period. The specialist nurse responds to the referrals, according to a standardized algorithm. In addition, all patients receive: * CEA and CT of the chest, abdomen and pelvis at 1 and 3 years after surgery * perioperative clean colon colonoscopy, and then every 5 years until the age of 75 years Only for patients with a stoma: \- access to stoma care by specialist nurses

OTHER

Standard follow-up

Patients with sphincter-preserving resection: \- outpatient visits incl. rectoscopy at 6, 12, 18, 24 and 36 months Patients with rectal amputation and a permanent stoma: * outpatient visits at 3, 12 and 36 months * access to stoma care by specialist nurses All patients: * CEA and CT of the chest, abdomen and pelvis at 1 and 3 years after surgery * perioperative clean colon colonoscopy, and then every 5 years until the age of 75 years

Sponsors & Collaborators

  • Danish Cancer Society

    collaborator OTHER
  • Herning Hospital

    collaborator OTHER
  • Aalborg University Hospital

    collaborator OTHER
  • Randers Regional Hospital

    collaborator OTHER
  • Aarhus University Hospital

    lead OTHER

Principal Investigators

  • Søren Laurberg, Prof. Dr.Med · Aarhus University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-02-26
Primary Completion
2021-08-31
Completion
2021-08-31

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03622437 on ClinicalTrials.gov